Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

318 ARTÍCULOS , VIENDO DEL 256 AL 270

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

Winblad B, Andreasen N, Minthon L, Floesser A, Imbert G, Dumortier T, Maguire RP, Blennow K, Lundmark J, Staufenbiel M, Orgogozo JM, Graf A.

Lancet Neurol. 2012 Jul;11(7):597-604. doi: 10.1016/S1474-4422(12)70140-0. Epub 2012 Jun 6.

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease

Tariot P, Salloway S, Yardley J, Mackell J, Moline M.

BMC Res Notes. 2012 Jun 8;5:283. doi: 10.1186/1756-0500-5-283.

Gene transfer to skeletal muscle by site-specific delivery of electroporation and ultrasound

Li Y, Wang J, Satterle A, Wu Q, Wang J, Liu F.

Biochem Biophys Res Commun. 2012 Jul 27;424(2):203-7. doi: 10.1016/j.bbrc.2012.06.090. Epub 2012 Jun 26.

Corticosteroids, but not NSAIDs, are associated with less Alzheimer neuropathology

Beeri MS, Schmeidler J, Lesser GT, Maroukian M, West R, Leung S, Wysocki M, Perl DP, Purohit DP, Haroutunian V.

Neurobiol Aging. 2012 Jul;33(7):1258-64. doi: 10.1016/j.neurobiolaging.2011.02.011. Epub 2011 Apr 1.

Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial

Leoutsakos JM, Muthen BO, Breitner JC, Lyketsos CG; ADAPT Research Team.

Int J Geriatr Psychiatry. 2012 Apr;27(4):364-74. doi: 10.1002/gps.2723. Epub 2011 May 10.

A community-based exercise programme to improve functional ability in people with Alzheimer's disease: a randomized controlled trial

Vreugdenhil A, Cannell J, Davies A, Razay G.

Scand J Caring Sci. 2012 Mar;26(1):12-9. doi: 10.1111/j.1471-6712.2011.00895.x. Epub 2011 May 12.

Do tocotrienols have potential as neuroprotective dietary factors?

Frank J, Chin XW, Schrader C, Eckert GP, Rimbach G.

Ageing Res Rev. 2012 Jan;11(1):163-80. doi: 10.1016/j.arr.2011.06.006. Epub 2011 Jul 7.

Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI

Holland D, McEvoy LK, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2012 Nov;33(11):2586-602. doi: 10.1002/hbm.21386. Epub 2011 Aug 9.

Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection

Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A.

Cell Tissue Res. 2012 Jan;347(1):291-301. doi: 10.1007/s00441-011-1230-6. Epub 2011 Aug 31.

Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4

Chen S, Liu AR, An FM, Yao WB, Gao XD.

Age (Dordr). 2012 Oct;34(5):1211-24. doi: 10.1007/s11357-011-9303-8. Epub 2011 Sep 8.

Assessment of the information provided by the medical specialist on Alzheimer's disease and that retained by the patient caregivers

Molinuevo JL, Hernández B; Grupo de Trabajo del Estudio TRACE.

Neurologia. 2012 Oct;27(8):453-71. doi: 10.1016/j.nrl.2011.05.009. Epub 2011 Sep 9.

Selective liver X receptor modulators (SLiMs): what use in human health?

Viennois E, Mouzat K, Dufour J, Morel L, Lobaccaro JM, Baron S.

Mol Cell Endocrinol. 2012 Apr 4;351(2):129-41. doi: 10.1016/j.mce.2011.08.036. Epub 2011 Sep 1.

Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review

Thompson PA, Wright DE, Counsell CE, Zajicek J.

Int Psychogeriatr. 2012 May;24(5):689-97. doi: 10.1017/S1041610211001116. Epub 2011 Sep 13.

Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease

Guan JZ, Guan WP, Maeda T, Makino N.

Gerontology. 2012;58(1):62-9. doi: 10.1159/000327821. Epub 2011 Sep 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias